DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,867,260 | +2.1% | 76,047 | -1.2% | 0.73% | +4.6% |
Q2 2023 | $18,474,960 | -4.8% | 76,979 | -0.1% | 0.70% | -10.5% |
Q1 2023 | $19,415,649 | -7.4% | 77,034 | -2.4% | 0.78% | -10.6% |
Q4 2022 | $20,959,685 | +1.6% | 78,968 | -1.2% | 0.87% | -8.5% |
Q3 2022 | $20,635,000 | +0.2% | 79,890 | -1.6% | 0.95% | +5.7% |
Q2 2022 | $20,592,000 | -14.4% | 81,227 | -1.0% | 0.90% | -2.7% |
Q1 2022 | $24,063,000 | -12.6% | 82,032 | -1.9% | 0.93% | -8.1% |
Q4 2021 | $27,519,000 | +4.6% | 83,642 | -3.2% | 1.01% | -2.9% |
Q3 2021 | $26,300,000 | +10.0% | 86,387 | -3.0% | 1.04% | +9.8% |
Q2 2021 | $23,905,000 | +37.4% | 89,078 | -29.1% | 0.95% | -12.5% |
Q1 2021 | $17,393,000 | -32.2% | 125,663 | +8.9% | 1.08% | +8.0% |
Q4 2020 | $25,643,000 | -2.8% | 115,433 | -5.8% | 1.00% | -11.8% |
Q3 2020 | $26,377,000 | +3.5% | 122,496 | -15.0% | 1.14% | -1.3% |
Q2 2020 | $25,486,000 | +23.4% | 144,134 | -3.4% | 1.15% | +4.5% |
Q1 2020 | $20,660,000 | -9.1% | 149,264 | +0.8% | 1.10% | -2.7% |
Q4 2019 | $22,719,000 | +3.9% | 148,026 | -2.2% | 1.13% | -3.7% |
Q3 2019 | $21,858,000 | -32.9% | 151,339 | -33.6% | 1.18% | -34.1% |
Q2 2019 | $32,552,000 | +7.0% | 227,762 | -1.1% | 1.78% | +1.8% |
Q1 2019 | $30,412,000 | +29.5% | 230,361 | +1.2% | 1.75% | +14.5% |
Q4 2018 | $23,482,000 | -7.4% | 227,717 | -2.5% | 1.53% | +8.8% |
Q3 2018 | $25,368,000 | +6.7% | 233,464 | -3.1% | 1.41% | +1.2% |
Q2 2018 | $23,774,000 | -2.8% | 240,921 | -3.6% | 1.39% | -0.1% |
Q1 2018 | $24,458,000 | -6.6% | 249,797 | -11.5% | 1.39% | -1.6% |
Q4 2017 | $26,190,000 | +8.7% | 282,149 | +0.5% | 1.41% | +6.3% |
Q3 2017 | $24,089,000 | +3.5% | 280,822 | +1.8% | 1.33% | +0.6% |
Q2 2017 | $23,281,000 | +5.2% | 275,876 | +6.6% | 1.32% | +0.2% |
Q1 2017 | $22,136,000 | +9.0% | 258,804 | -0.8% | 1.32% | +3.9% |
Q4 2016 | $20,308,000 | +0.4% | 260,886 | +1.1% | 1.27% | -1.6% |
Q3 2016 | $20,228,000 | -14.1% | 258,050 | +10.7% | 1.29% | -14.8% |
Q2 2016 | $23,538,000 | +8.2% | 233,042 | +1.6% | 1.51% | +5.7% |
Q1 2016 | $21,761,000 | +2.2% | 229,397 | +0.1% | 1.43% | +1.8% |
Q4 2015 | $21,290,000 | +10.5% | 229,222 | +1.4% | 1.40% | +4.5% |
Q3 2015 | $19,263,000 | +0.5% | 226,070 | +1.0% | 1.34% | +9.4% |
Q2 2015 | $19,163,000 | +2.2% | 223,895 | +1.4% | 1.23% | +3.9% |
Q1 2015 | $18,745,000 | -1.4% | 220,790 | -0.4% | 1.18% | -1.3% |
Q4 2014 | $19,002,000 | +14.7% | 221,697 | +1.6% | 1.20% | +10.2% |
Q3 2014 | $16,572,000 | -0.0% | 218,105 | +3.6% | 1.09% | +0.9% |
Q2 2014 | $16,579,000 | +5.0% | 210,577 | +0.0% | 1.08% | -1.0% |
Q1 2014 | $15,788,000 | -2.3% | 210,505 | +0.6% | 1.09% | -6.1% |
Q4 2013 | $16,157,000 | +10.2% | 209,288 | -1.1% | 1.16% | -0.3% |
Q3 2013 | $14,665,000 | +0.5% | 211,555 | -8.3% | 1.16% | -2.9% |
Q2 2013 | $14,598,000 | – | 230,613 | – | 1.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |